Delivering Cell & Gene Therapies Through Community Sites From Access To Execution

At the ASGCT 2026 Annual Meeting, global leaders in cell and gene therapy met to advance innovation in translational science and treatment delivery. During the event, Parexel held a symposium focused on rethinking how cell and gene therapies are delivered through community-based treatment sites. The session examines how bringing therapy administration closer to patients can improve access, equity, and inclusion while addressing critical operational barriers in advanced therapy deployment. Additionally, these delivery approaches can enhance data quality and availability, ultimately improving patient identification, accelerating enrollment, and strengthening evidence for regulatory submissions and clinical decision-making in cell and gene therapy development.